{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T06:10:24Z","timestamp":1794031824953,"version":"4.8.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T00:00:00Z","timestamp":1705449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T00:00:00Z","timestamp":1705449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objection<\/jats:title>\n                <jats:p>Inflammatory conditions and immune disorders may worsen the prognosis of chronic heart failure (CHF) patients. The aim of this study was to evaluate the prognostic value of a new indicator, C-NLR, composed of C-reactive protein (CRP) and neutrophil-to-lymphocyte ratio (NLR), for the risk of all-cause mortality in HF patients with different ejection fractions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 1221 CHF patients admitted to the First Affiliated Hospital of Kunming Medical University from January 2017 to October 2021 were enrolled in this study. All patients were divided into 2 groups according to the median C-NLR. Kaplan\u2013Meier survival curves were used to compare the all-cause mortality among CHF patients with different ejection fractions. Cox proportional hazards analysis was used to evaluate the relationships between variables and mortality. The predictive value of the C-NLR was assessed by using receiver operating characteristic (ROC) analyses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We collected data from 1192 patients with CHF. Kaplan\u2013Meier survival analysis revealed that patients with low LCR levels had better overall survival (OS). After multivariate adjustment Cox proportional hazards analysis, the level of C-NLR was still independently related to mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>C-NLR was a competent independent predictor in HF with different ejection fractions, and routine measurement of C-NLR would help clinical doctors identify patients with a poor prognosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-024-03714-4","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T15:02:22Z","timestamp":1705503742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical prognostic impact of C-NLR in heart failure patients with different ejection fractions: a retrospective study"],"prefix":"10.1186","volume":"24","author":[{"given":"Fazhi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,17]]},"reference":[{"key":"3714_CR1","doi-asserted-by":"publisher","first-page":"e008406","DOI":"10.1161\/CIRCHEARTFAILURE.121.008406","volume":"14","author":"H Wang","year":"2021","unstructured":"Wang H, Chai K, Du M, Wang S, Cai J-P, Li Y, et al. Prevalence and incidence of heart failure among urban patients in China: a National Population-Based Analysis. Circulation Heart Fail. 2021;14:e008406.","journal-title":"Circulation Heart Fail."},{"key":"3714_CR2","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ejhf.2115","volume":"23","author":"B Bozkurt","year":"2021","unstructured":"Bozkurt B, Coats AJS, Tsutsui H, Abdelhamid CM, Adamopoulos S, Albert N, et al. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, heart failure Association of the European Society of cardiology, Japanese heart failure society and writing Committee of the Universal Definition of heart failure: endorsed by the Canadian heart failure society, heart failure Association of India, Cardiac Society of Australia and new Zealand, and Chinese heart failure association. Eur J Heart Fail. 2021;23:352\u201380.","journal-title":"Eur J Heart Fail."},{"key":"3714_CR3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s11897-017-0337-9","volume":"14","author":"S Van Linthout","year":"2017","unstructured":"Van Linthout S, Tsch\u00f6pe C. Inflammation \u2013 cause or consequence of heart failure or both? Curr Heart Fail Rep. 2017;14:251\u201365.","journal-title":"Curr Heart Fail Rep."},{"key":"3714_CR4","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","volume":"75","author":"SP Murphy","year":"2020","unstructured":"Murphy SP, Kakkar R, McCarthy CP, Januzzi JL. Inflammation in heart failure. J Am Coll Cardiol. 2020;75:1324\u201340.","journal-title":"J Am Coll Cardiol."},{"key":"3714_CR5","doi-asserted-by":"crossref","unstructured":"Tang X, Wang P, Zhang R, Watanabe I, Chang E, Vinayachandran V, et al. KLF2 regulates neutrophil activation and thrombosis in cardiac hypertrophy and heart failure progression. J Clin Invest. 2022;132:e147191.","DOI":"10.1172\/JCI147191"},{"key":"3714_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/cvr\/cvz198","volume":"116","author":"P Pellicori","year":"2020","unstructured":"Pellicori P, Zhang J, Cuthbert J, Urbinati A, Shah P, Kazmi S, et al. High-sensitivity C-reactive protein in chronic heart failure: patient characteristics, phenotypes, and mode of death. Cardiovasc Res. 2020;116:91\u2013100.","journal-title":"Cardiovasc Res."},{"key":"3714_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ijcard.2015.04.043","volume":"188","author":"M Mar\u00e7ula","year":"2015","unstructured":"Mar\u00e7ula M, de Souza Buto MF, Madaloso BA, Nunes RAB, Cuoco MAR, de Paula RS, et al. Lymphocyte count and prognosis in patients with heart failure. Int J Cardiol. 2015;188:60\u20132.","journal-title":"Int J Cardiol."},{"key":"3714_CR8","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1007\/s10147-021-01964-2","volume":"26","author":"T Taniai","year":"2021","unstructured":"Taniai T, Haruki K, Furukawa K, Onda S, Yasuda J, Shirai Y, et al. The novel index using preoperative C-reactive protein and neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with pancreatic cancer. Int J Clin Oncol. 2021;26:1922\u20138.","journal-title":"Int J Clin Oncol."},{"key":"3714_CR9","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","volume":"9","author":"NR Sproston","year":"2018","unstructured":"Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754.","journal-title":"Front Immunol."},{"key":"3714_CR10","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1161\/01.CIR.0000057810.48709.F6","volume":"107","author":"RS Vasan","year":"2003","unstructured":"Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, et al. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham heart study. Circulation. 2003;107:1486\u201391.","journal-title":"Circulation."},{"key":"3714_CR11","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1084\/jem.190.12.1733","volume":"190","author":"M Griselli","year":"1999","unstructured":"Griselli M, Herbert J, Hutchinson WL, Taylor KM, Sohail M, Krausz T, et al. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med. 1999;190:1733\u201340.","journal-title":"J Exp Med."},{"key":"3714_CR12","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1056\/NEJMoa021993","volume":"347","author":"PM Ridker","year":"2002","unstructured":"Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557\u201365.","journal-title":"N Engl J Med."},{"key":"3714_CR13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3109\/07853890009011772","volume":"32","author":"TW Du Clos","year":"2000","unstructured":"Du Clos TW. Function of C-reactive protein. Ann Med. 2000;32:274\u20138.","journal-title":"Ann Med."},{"key":"3714_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2147\/vhrm.2006.2.3.221","volume":"2","author":"R Osman","year":"2006","unstructured":"Osman R, L\u2019Allier PL, Elgharib N, Tardif J-C. Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease. Vasc Health Risk Manag. 2006;2:221\u201337.","journal-title":"Vasc Health Risk Manag."},{"key":"3714_CR15","doi-asserted-by":"publisher","first-page":"1064967","DOI":"10.3389\/fcvm.2022.1064967","volume":"9","author":"JJ Park","year":"2022","unstructured":"Park JJ, Yoon M, Cho H-W, Cho H-J, Kim KH, Yang DH, et al. C-reactive protein and statins in heart failure with reduced and preserved ejection fraction. Front Cardiovascular Med. 2022;9:1064967.","journal-title":"Front Cardiovascular Med."},{"key":"3714_CR16","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1161\/01.ATV.20.9.2094","volume":"20","author":"M Torzewski","year":"2000","unstructured":"Torzewski M, Rist C, Mortensen RF, Zwaka TP, Bienek M, Waltenberger J, et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol. 2000;20:2094\u20139.","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"3714_CR17","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12933-021-01346-y","volume":"20","author":"V Quagliariello","year":"2021","unstructured":"Quagliariello V, De Laurentiis M, Rea D, Barbieri A, Monti MG, Carbone A, et al. The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin. Cardiovasc Diabetol. 2021;20:150.","journal-title":"Cardiovasc Diabetol."},{"key":"3714_CR18","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1002\/ejhf.942","volume":"19","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Bauersachs J, Langer HF. Immune mechanisms in heart failure: heart failure and immune mechanisms. Eur J Heart Fail. 2017;19:1379\u201389.","journal-title":"Eur J Heart Fail."},{"key":"3714_CR19","doi-asserted-by":"crossref","unstructured":"Parish RC, Miller LJ. Adverse effects of angiotensin converting enzyme (ACE) inhibitors. An update. Drug Saf. 1992;7:14\u201331.","DOI":"10.2165\/00002018-199207010-00004"},{"key":"3714_CR20","doi-asserted-by":"publisher","first-page":"4534","DOI":"10.1182\/blood-2008-12-192559","volume":"113","author":"K Maeda","year":"2009","unstructured":"Maeda K, Malykhin A, Teague-Weber BN, Sun X-H, Farris AD, Coggeshall KM. Interleukin-6 aborts lymphopoiesis and elevates production of myeloid cells in systemic lupus erythematosus-prone B6.Sle1.Yaa animals. Blood. 2009;113:4534\u201340.","journal-title":"Blood."},{"key":"3714_CR21","first-page":"565","volume":"43","author":"TW Du Clos","year":"1981","unstructured":"Du Clos TW, Mold C, Paterson PY, Alroy J, Gewurz H. Localization of C-reactive protein in inflammatory lesions of experimental allergic encephalomyelitis. Clin Exp Immunol. 1981;43:565\u201373.","journal-title":"Clin Exp Immunol."},{"key":"3714_CR22","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jtcvs.2008.05.046","volume":"137","author":"KM Sarraf","year":"2009","unstructured":"Sarraf KM, Belcher E, Raevsky E, Nicholson AG, Goldstraw P, Lim E. Neutrophil\/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2009;137:425\u20138.","journal-title":"J Thorac Cardiovasc Surg."},{"key":"3714_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1067\/mhj.2001.115792","volume":"142","author":"D Acanfora","year":"2001","unstructured":"Acanfora D, Gheorghiade M, Trojano L, Furgi G, Pasini E, Picone C, et al. Relative lymphocyte count: a prognostic indicator of mortality in elderly patients with congestive heart failure. Am Heart J. 2001;142:167\u201373.","journal-title":"Am Heart J."},{"key":"3714_CR24","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ajem.2005.10.010","volume":"24","author":"A Rudiger","year":"2006","unstructured":"Rudiger A, Burckhardt OA, Harpes P, M\u00fcller SA, Follath F. The relative lymphocyte count on hospital admission is a risk factor for long-term mortality in patients with acute heart failure. Am J Emerg Med. 2006;24:451\u20134.","journal-title":"Am J Emerg Med."},{"key":"3714_CR25","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.amjcard.2010.09.039","volume":"107","author":"S Uthamalingam","year":"2011","unstructured":"Uthamalingam S, Patvardhan EA, Subramanian S, Ahmed W, Martin W, Daley M, et al. Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure. Am J Cardiol. 2011;107:433\u20138.","journal-title":"Am J Cardiol."},{"key":"3714_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.amjcard.2014.10.008","volume":"115","author":"VA Benites-Zapata","year":"2015","unstructured":"Benites-Zapata VA, Hernandez AV, Nagarajan V, Cauthen CA, Starling RC, Tang WHW. Usefulness of neutrophil-to-lymphocyte ratio in risk stratification of patients with advanced heart failure. Am J Cardiol. 2015;115:57\u201361.","journal-title":"Am J Cardiol."},{"key":"3714_CR27","doi-asserted-by":"crossref","unstructured":"Tamaki S, Nagai Y, Shutta R, Masuda D, Yamashita S, Seo M, et al. Combination of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as a novel predictor of cardiac death in patients with acute decompensated heart failure with preserved left ventricular ejection fraction: a multicenter study. J Am Heart Assoc. 2023:12.","DOI":"10.1161\/JAHA.122.026326"},{"key":"3714_CR28","doi-asserted-by":"publisher","first-page":"762470","DOI":"10.3389\/fonc.2021.762470","volume":"11","author":"Y Wang","year":"2021","unstructured":"Wang Y, Wang K, Ni J, Zhang H, Yin L, Zhang Y, et al. Combination of C-reactive protein and neutrophil-to-lymphocyte ratio as a novel prognostic index in patients with bladder Cancer after radical cystectomy. Front Oncol. 2021;11:762470.","journal-title":"Front Oncol."},{"key":"3714_CR29","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S1388-9842(02)00021-1","volume":"4","author":"JL Alonso-Mart\u00ednez","year":"2002","unstructured":"Alonso-Mart\u00ednez JL, Llorente-Diez B, Echegaray-Agara M, Olaz-Preciado F, Urbieta-Echezarreta M, Gonz\u00e1lez-Arencibia C. C-reactive protein as a predictor of improvement and readmission in heart failure. Eur J Heart Fail. 2002;4:331\u20136.","journal-title":"Eur J Heart Fail."}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-03714-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-024-03714-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-03714-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T15:04:18Z","timestamp":1705503858000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-024-03714-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,17]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3714"],"URL":"https:\/\/doi.org\/10.1186\/s12872-024-03714-4","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,17]]},"assertion":[{"value":"2 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Medical Ethics Committee of the First Affiliated Hospital of Kunming Medical University and was in line with the guidelines of the World Medical Association Declaration of Helsinki. All patients gave written informed consent for their data to be electronically stored and used for research. The ethics number of the study was (2022) Ethics L No.173.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}